This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at all stages of the drug discovery and design journey. Robust process ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism ...

Dr Kaitin writes and speaks frequently on factors that contribute to the slow pace and high cost of pharmaceutical R&amp,D and the impact of efforts to speed the drug development process.

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

In this episode of Drug Digest, industry experts discuss their experiences in dealing with the challenges of developing and manufacturing next-generation biotherapeutics as well as triumphs that move ...

Most AI researchers can tackle specific tasks in the drug development process when provided with high-quality data and particular questions to answer. But they are often unfamiliar with the full ...

The pharmaceutical industry ... covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process scale-up, large-scale manufacturing ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

Another promising avenue of research focuses on repurposing drugs for tumor treatment. This approach offers a valuable means of discovering new cancer treatments by utilizing drugs already approved ...

ASTX-295 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success ...

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower ... speeding up the overall trial process. In 2025, I think ...